JP2009527484A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009527484A5 JP2009527484A5 JP2008555417A JP2008555417A JP2009527484A5 JP 2009527484 A5 JP2009527484 A5 JP 2009527484A5 JP 2008555417 A JP2008555417 A JP 2008555417A JP 2008555417 A JP2008555417 A JP 2008555417A JP 2009527484 A5 JP2009527484 A5 JP 2009527484A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- zileuton
- composition according
- single crystal
- powder diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77557906P | 2006-02-21 | 2006-02-21 | |
| PCT/US2007/004488 WO2007098189A2 (en) | 2006-02-21 | 2007-02-21 | New crystal forms and pharmaceutical compositions of (+) -r-zileuton |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009527484A JP2009527484A (ja) | 2009-07-30 |
| JP2009527484A5 true JP2009527484A5 (https=) | 2010-04-08 |
Family
ID=38437967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008555417A Pending JP2009527484A (ja) | 2006-02-21 | 2007-02-21 | （＋）−ｒ−ジロートンの新規結晶形態および医薬組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8003684B2 (https=) |
| EP (2) | EP2409973A1 (https=) |
| JP (1) | JP2009527484A (https=) |
| AU (1) | AU2007217770B2 (https=) |
| CA (1) | CA2642216A1 (https=) |
| WO (1) | WO2007098189A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8445437B2 (en) * | 2006-07-27 | 2013-05-21 | The Brigham And Women's Hospital, Inc. | Treatment and prevention of cardiovascular disease using mast cell stabilizers |
| CN101674823A (zh) * | 2007-01-05 | 2010-03-17 | 基础治疗公司 | 用于与增强的5-脂氧合酶和/或白三烯活性有关的疾病（例如哮喘）的r-齐留通 |
| CN101808642B (zh) | 2007-09-28 | 2012-05-02 | 布里格海姆妇女医院公司 | 肥大细胞稳定剂治疗肥胖症 |
| SG175390A1 (en) | 2009-04-29 | 2011-12-29 | Amarin Corp Plc | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| CA2844775A1 (en) * | 2011-08-23 | 2013-02-28 | Cornerstone Therapeutics Inc. | Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients |
| US9855243B2 (en) | 2013-10-30 | 2018-01-02 | Qurient Co., Ltd. | Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation |
| KR101462474B1 (ko) * | 2013-10-30 | 2014-11-19 | 주식회사 큐리언트 | 질레우톤 크림 제형의 국소용 항염증 약학적 조성물 |
| AU2015276857B2 (en) * | 2014-06-20 | 2017-10-19 | Vaxart, Inc. | Anhydrous crystalline free base form of-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US279263A (en) * | 1883-06-12 | Eobeet t | ||
| ES2059408T3 (es) * | 1987-02-10 | 1994-11-16 | Abbott Lab | Un proceso para la preparacion de un compuesto. |
| EP0697868A4 (en) * | 1993-05-10 | 1998-04-08 | Sepracor Inc | THERAPIES AND COMPOSITIONS USING OPTICALLY PURE (+) - ZILEUTON |
| JPH09500139A (ja) * | 1993-07-14 | 1997-01-07 | スミスクライン・ビーチャム・コーポレイション | ヒドロキシルアミンの酸付加塩の合成法 |
-
2007
- 2007-02-21 JP JP2008555417A patent/JP2009527484A/ja active Pending
- 2007-02-21 EP EP11176982A patent/EP2409973A1/en not_active Withdrawn
- 2007-02-21 AU AU2007217770A patent/AU2007217770B2/en not_active Ceased
- 2007-02-21 US US11/709,299 patent/US8003684B2/en not_active Expired - Fee Related
- 2007-02-21 WO PCT/US2007/004488 patent/WO2007098189A2/en not_active Ceased
- 2007-02-21 EP EP07751259A patent/EP2001861A2/en not_active Ceased
- 2007-02-21 CA CA002642216A patent/CA2642216A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009527484A5 (https=) | ||
| US20230373955A1 (en) | Synthesis of omecamtiv mecarbil | |
| US10035802B2 (en) | Solid state forms of ibrutinib | |
| JP2013529647A5 (https=) | ||
| JP2014515372A5 (https=) | ||
| JP2019505568A5 (https=) | ||
| WO2014152270A1 (en) | Salt of omecamtiv mecarbil and process for preparing salt | |
| HUE031416T2 (en) | Preparation of 2- (5-Bromo-4- (4-cyclopropylnaphthalen-1-hydrazine) -4H-1,2,4-triazole-3-hydrazine) acetic acid \ t | |
| CN108947891B (zh) | 利用三光气安全制备匹莫范色林及其酒石酸盐的方法 | |
| JP2007514746A5 (https=) | ||
| JP6556293B2 (ja) | 純粋なニロチニブ及びその塩の調製のための方法 | |
| US10519117B2 (en) | Crystal forms of 6-bromo-3-hydroxy-2-pyrazinecarboxamide | |
| WO2016107289A1 (zh) | 制备索非布韦晶型6的方法 | |
| CN104628679A (zh) | Bitopertin的新合成方法及其中间体 | |
| CN102321073A (zh) | 一种尼罗替尼的制备方法 | |
| JP2013541589A5 (https=) | ||
| CN103951601B (zh) | 2-乙酰基-1-吡咯啉的合成方法 | |
| ES2710312T3 (es) | Un procedimiento para la preparación de montelukast sódico | |
| CN105777617A (zh) | 色瑞替尼的合成中间体及其制备方法 | |
| JP6387349B2 (ja) | 逆転写酵素阻害剤の結晶形態 | |
| WO2012153225A1 (en) | Improved processes for obtaining high purity of dronedarone hydrochloride | |
| CN101896496B (zh) | 4-脱氧-4-氟-d-葡萄糖衍生物的制造方法 | |
| EP3374349A1 (en) | Process for the preparation of eltrombopag olamine | |
| JPWO2005058914A1 (ja) | オキサセフェムの結晶 | |
| NZ800862A (en) | Form-i crystal of 2-{ 4-[n-(5,6-diphenylpyrazin-2-yl)-n-isopropylamino]butyloxy} acetic acid |